Article
San Diego-Treatment with the dual neurotransmitter reuptake inhibitor duloxetine (Yentreve) results in durable improvement in symptoms of stress urinary incontinence, according to a study of open-label transition from placebo to active therapy.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.